North America Biopharmaceuticals Market Size, Share & Global Insights 2022-2028

The North America biopharmaceuticals market was valued at US$ 151.22 billion in 2022 and is expected to reach US$ 315.74 billion by 2028. It is estimated to register a CAGR of 13.1% from 2022 to 2028.
According to the National Institute of Health (NIH) report, 30 million Americans, accounting for 10% of the population, have one of the ~7,000 known rare diseases. Developing medicines for treating these rare diseases presents both scientific and operational challenges. Complex biology associated with rare diseases presents challenges for scientists to design and implement new drug development programs. However, despite these challenges, biopharmaceutical researchers in the North Americas have developed new technologies for treating rare diseases and developing ground breaking therapies. Moreover, in the last decade, 350 orphan drugs have been approved by USFDA, particularly for conditions lacking treatment or having limited treatment options. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a life-threatening, progressive cardiovascular rare disease characterized by the abnormal functioning of the heart, causing infiltrative cardiomyopathy. Once diagnosed, the median life expectancy is only ~2.5-3.5 years if left untreated. Further, biopharmaceuticals company Ultra genyx Pharmaceutical Inc. is engaged in the safety testing and dosage determination of molecules developed to treat Glycogen Storage Disease (GSD) type 3, a serious rare and ultra-genetic disease.

Grab PDF To Know More @ https://www.businessmarketinsights.com/sample/BMIRE00028630?utm_source=OpenPR&utm_medium=10844

Biopharmaceuticals Market Overview
The North America biopharmaceuticals market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing incidence of cancer, growing product introduction in the region, and technological advancements in biopharmaceuticals. The biopharmaceuticals industry is at a pivotal stage in medical research with tremendous potential to further revolutionize the treatment of costly and debilitating diseases such as Alzheimer's, cancer, heart disease, and hepatitis C. The rising burden of chronic diseases and increased investment in research and development activities in the US are driving the market in the region. The biopharmaceuticals industry makes important contributions to the US economy. The US leads the world in most R&D investment and innovation indices.

MARKET INTRODUCTION

The North America biopharmaceuticals market is segmented into product type, application, and country.

Based on product type, the North America biopharmaceuticals market is segmented into monoclonal antibodies, recombinant vaccines, conventional vaccines, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, recombinant enzymes, cell & gene therapies, cytokines/interferon/interleukins, and others. In 2022, the monoclonal antibodies
List of Companies Profiled in the Biopharmaceuticals Market Report are:
• AbbVie Inc
• AGC Biologics AS
• Amgen Inc
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co
• Eli Lilly and Co
• Johnson & Johnson
• Lonza Group AG
• Thermo Fisher Scientific Inc
• WuXi Biologics Inc

@ https://www.businessmarketinsights.com/buy/single/BMIRE00028630?utm_source=OpenPR&utm_medium=10844

Key Segmentation:

Deployment Mode (Cloud Based and On-Premise),
The Biopharmaceuticals Market is categorized into type, application, and country.
• Based on type, the Biopharmaceuticals Market is segmented into pellets, blocks, and others. The blocks segment held the largest market share in 20220
• In terms of application, the Biopharmaceuticals Market is segmented into food and beverage, storage and transportation, healthcare, industrial applications, and others. The storage and transportation held the largest market share in 2022.
• By country, the Biopharmaceuticals Market is segmented into the US, Canada, and Mexico. The US dominated the Biopharmaceuticals Markets hare in 2022.
North America Biopharmaceuticals Market, in 2021. The growth of the segment is primarily attributed to the increase in need for maintenance and repair activities in order to make sure its internal and external parts are in good condition and to maintain a record of its condition. Based on application, the power transformers segment held the largest share of the North America Biopharmaceuticals Market. The rise in energy demand, increase in renewable power generation, growing initiatives for smart cities & urbanization are the key factors responsible for the demand of power transformer. Thus, such factors are driving the North America Biopharmaceuticals Market growth.

Table of Contents

Based on material, the Mexico Logistics market is segmented into FRP/composites, metal/alloys, and others. The metal/alloys segment held the largest share of the North America Biopharmaceuticals Market in 2022.
Based on size, the Mexico Logistics market is segmented into 75-120 feet, 121-250 feet, and Above 250 feet. The 121-250 feet segment held the largest share of the North America Biopharmaceuticals Market in 2022.

Based on country, the North America Biopharmaceuticals Market is segmented into France, Germany, the UK, Italy, Russia, and the Rest of Europe. The Rest of Europe dominated the share of the North America Biopharmaceuticals Market in 2022.

Contact us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Ankit Mathur
Email: sales@businessmarketinsights.com
Phone: +16467917070

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.